NCT00162253 - Study of BMS-587101 in Patients With Moderate to Severe Psoriasis | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2006

Conditions

Psoriasis, Moderate to Severe

Interventions

DRUG

BMS 587101

Trial Locations (16)

Local Institution, Phoenix

Local Institution, Tucson

Local Institution, San Diego

Local Institution, Miami Beach

Local Institution, Pinellas Park

Local Institution, Boise

Local Institution, Fridley

Local Institution, St Louis

Local Institution, New Brunswick

Local Institution, New York

Local Institution, Winston-Salem

Local Institution, Columbus

Local Institution, Portland

Local Institution, Philadelphia

Local Institution, Greer

Local Institution, Dallas